Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-15 | Dr. Alison L. Hannah, age 60. Dr. Hannah has served as a director since June 2015. Dr. Hannah has over 30 years' experience in the development of investigational cancer chemotherapies. |
| 2022-04-14 | Dr. Alison L. Hannah, age 61, Board Member and Chair of the Compliance Committee. Dr. Hannah has served as a director since June 2015. ... Dr. Hannah has a BS in biochemistry and immunology from Harvard University and a medical degree from the University of Saint Andrews. ... Dr. Alison L. Hannah 61,736 Fees Earned or Paid in Cash, 126,000 Stock Awards, 54,000 Option Awards, Total 241,736. |
| 2025-04-08 | Dr. Alison L. Hannah - Dr. Hannah has served as a director since June 2015. She is Chair of the Compliance Committee and serves on the Audit and Finance Committee, Culture and Compensation Committee, and Nominating and Corporate Governance Committee. For service as a director during 2024, Dr. Hannah received total compensation of $309,382. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-19